Keyphrases
Ethinylestradiol
100%
Nestorone
100%
Vaginal Ring
100%
Dose-finding Trial
100%
Breakthrough Bleeding
50%
Colposcopy
50%
In Situ
25%
Adverse Events
25%
Luteal Function
25%
Ovulation Inhibition
25%
In Vitro Release
25%
Device Loss
25%
Progesterone
25%
Long-acting Reversible Contraception
25%
Bleeding
25%
Progestin
25%
Level Control
25%
Medical Conditions
25%
Personal Reasons
25%
Dose Combination
25%
Ringing Effect
25%
Personal Devices
25%
Serum Drug Levels
25%
Bleeding Control
25%
Drug Release Rate
25%
Standardized Interpretation
25%
Clinical Performance
25%
Adverse Events Profile
25%
Performance Event
25%
Medicine and Dentistry
Vagina Ring
100%
Ethinylestradiol
100%
Elcometrine
100%
Adverse Event
50%
Dysfunctional Uterine Bleeding
50%
Colposcopy
50%
In Vitro
25%
Gestagen
25%
Progesterone
25%
Bleeding
25%
Ovulation Inhibition
25%
Isoprenaline
25%
Spotting
25%
Pharmacology, Toxicology and Pharmaceutical Science
Ethinylestradiol
100%
Elcometrine
100%
Adverse Event
50%
Metrorrhagia
50%
Bleeding
25%
Drug Release
25%
Progesterone
25%
Progestin
25%
Spotting
25%
Isoprenaline
25%